Publication | Closed Access

A UPLC–MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir

MedicineSimultaneous Plasma QuantificationUplc–ms/ms MethodAntiviral Drug DevelopmentHepatitisAntiviral TherapyIsomeric FormsAntiviral DrugPharmacologyAntiviral CompoundDrug Discovery